BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26237946)

  • 1. [The Spatial-Frequency Characteristics of the Visual System in Schizophrenia].
    Shoshina II; Shelepin YE; Vershinina EA; Novikova KO
    Fiziol Cheloveka; 2015; 41(3):29-40. PubMed ID: 26237946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The frequency-contrast sensitivity of visual stimulus perception in patients with schizophrenia with the therapy of atypical and typical antipsychotic drugs].
    Shoshina II; Shelepin IuE; Semenova NB
    Fiziol Cheloveka; 2014; 40(1):43-8. PubMed ID: 25272767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The contrast sensitivity in schizophrenia with different durations disease].
    Shoshina II; Shelepin IuE
    Ross Fiziol Zh Im I M Sechenova; 2013 Aug; 99(8):928-36. PubMed ID: 25470943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcortical visual dysfunction in schizophrenia drives secondary cortical impairments.
    Butler PD; Martinez A; Foxe JJ; Kim D; Zemon V; Silipo G; Mahoney J; Shpaner M; Jalbrzikowski M; Javitt DC
    Brain; 2007 Feb; 130(Pt 2):417-30. PubMed ID: 16984902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early stage vision in schizophrenia and schizotypal personality disorder.
    O'Donnell BF; Bismark A; Hetrick WP; Bodkins M; Vohs JL; Shekhar A
    Schizophr Res; 2006 Sep; 86(1-3):89-98. PubMed ID: 16829048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of parvocellular and magnocellular visual channels in normal subjects and in patients with psychopathology].
    Shoshina II; Shelepin IuE; Konkina SA; Pronin SV; Bendera AP
    Ross Fiziol Zh Im I M Sechenova; 2012 May; 98(5):657-64. PubMed ID: 22838200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast sensitivity and magnocellular functioning in schizophrenia.
    Skottun BC; Skoyles JR
    Vision Res; 2007 Oct; 47(23):2923-33. PubMed ID: 17825350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceptual and cognitive effects of antipsychotics in first-episode schizophrenia: the potential impact of GABA concentration in the visual cortex.
    Kelemen O; Kiss I; Benedek G; Kéri S
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():13-9. PubMed ID: 23954737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfunction of early-stage visual processing in schizophrenia.
    Butler PD; Schechter I; Zemon V; Schwartz SG; Greenstein VC; Gordon J; Schroeder CE; Javitt DC
    Am J Psychiatry; 2001 Jul; 158(7):1126-33. PubMed ID: 11431235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vernier threshold in patients with schizophrenia and in their unaffected siblings.
    Kéri S; Kelemen O; Benedek G; Janka Z
    Neuropsychology; 2004 Jul; 18(3):537-42. PubMed ID: 15291731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anomalous visual experiences, negative symptoms, perceptual organization and the magnocellular pathway in schizophrenia: a shared construct?
    Kéri S; Kiss I; Kelemen O; Benedek G; Janka Z
    Psychol Med; 2005 Oct; 35(10):1445-55. PubMed ID: 16164768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When doors of perception open: visual contrast sensitivity in never-medicated, first-episode schizophrenia.
    Kiss I; Fábián A; Benedek G; Kéri S
    J Abnorm Psychol; 2010 Aug; 119(3):586-93. PubMed ID: 20677847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatio-temporal luminance contrast sensitivity and visual backward masking in schizophrenia.
    Slaghuis WL
    Exp Brain Res; 2004 May; 156(2):196-211. PubMed ID: 14752582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low spatial frequency contrast sensitivity deficits in migraine are not visual pathway selective.
    McKendrick AM; Sampson GP
    Cephalalgia; 2009 May; 29(5):539-49. PubMed ID: 19250285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with schizophrenia show deficits on spatial frequency doubling.
    Khosravani N; Goodarzi MA
    Vision Res; 2013 Dec; 93():49-53. PubMed ID: 24140959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-stage vision and schizophrenia.
    Kéri S; Janka Z; Benedek G
    Am J Psychiatry; 2002 Apr; 159(4):678; author reply 678-9. PubMed ID: 11925325
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychophysical assessment of magno- and parvocellular function in schizophrenia.
    Delord S; Ducato MG; Pins D; Devinck F; Thomas P; Boucart M; Knoblauch K
    Vis Neurosci; 2006; 23(3-4):645-50. PubMed ID: 16962008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual information processing in patients with schizophrenia: evidence for the impairment of central mechanisms.
    Kéri S; Antal A; Szekeres G; Benedek G; Janka Z
    Neurosci Lett; 2000 Oct; 293(1):69-71. PubMed ID: 11065140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnocellular pathway impairment in schizophrenia: evidence from functional magnetic resonance imaging.
    Martínez A; Hillyard SA; Dias EC; Hagler DJ; Butler PD; Guilfoyle DN; Jalbrzikowski M; Silipo G; Javitt DC
    J Neurosci; 2008 Jul; 28(30):7492-500. PubMed ID: 18650327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual contrast sensitivity alterations in inferred magnocellular pathways and anomalous perceptual experiences in people at high-risk for psychosis.
    Kéri S; Benedek G
    Vis Neurosci; 2007; 24(2):183-9. PubMed ID: 17640409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.